Pierre Gravier

Pierre Gravier serves as the Chief Financial Officer at PTC Therapeutics, Inc. since July 2023. Prior to this role, Pierre held the position of Managing Director at Perella Weinberg Partners from April 2013 to July 2023 and worked as an Associate in Healthcare M&A at Barclays Capital between June 2009 and March 2013. Pierre also gained experience as a Venture Capital Analyst in Healthcare at SGAM in early 2008 and worked as a Bioengineer at Ferring Research Institute San Diego from July 2006 to March 2007. Pierre's educational background includes a Specialised Master Degree in Finance from ESCP Business School, a Master Degree of Science in Bioengineering and Innovation Management from Université de Technologie de Compiègne, and a Bachelor of Science with highest honours from UTBM.